RaQualia Pharma Inc.【JP:4579】Cash flow
Market cap
¥22B
P/E ratio
-391.1x
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Depreciation & amortization | 53 | 80 | 86 | 126 | 140 | 124 | 142 | 148 | 176 | 198 | 203 |
| Cash from operations | -2,117 | -681 | -307 | -404 | -531 | -289 | 366 | 1,480 | -719 | 181 | -354 |
| Capital expenditures | -196 | -36 | -88 | -213 | -71 | -150 | -91 | -31 | -204 | -97 | -67 |
| Cash from investing | 666 | -441 | 534 | -368 | 216 | 225 | -279 | -48 | -135 | -3,666 | 124 |
| Repurchases of common stock | - | - | -0 | - | - | - | - | - | - | -0 | - |
| Proceeds from issuance of term debt, net | - | - | - | - | - | - | - | 13 | 50 | 3,358 | - |
| Repayments of term debt | - | - | - | - | - | - | - | -1 | -10 | -388 | -513 |
| Cash from financing | 1,702 | - | 1,007 | 99 | 696 | -7 | -16 | -30 | 793 | 2,982 | 378 |